Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.

NCT03283384 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

100

Enrollment

NETWORK

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Letrozole
DRUG: Chemotherapy
DRUG: Ribociclib plus letrozole

Sponsor

Borstkanker Onderzoek Groep

Collaborators

[object Object]
[object Object]